Lady Gaga and Michael Polansky Pivot to AI-Driven Biotech

The core of the operation rests on YUNA, a proprietary platform that maintains full-thickness human skin tissue in a viable state for over 30 days. This allows researchers to monitor complex biological processes—such as collagen remodeling and chronic inflammation—far longer than standard laboratory methods. By integrating machine learning, the company predicts how untested compounds will interact with skin functions, effectively filtering candidates before physical testing begins. According to Polansky, this shift has transformed a process that previously required 18 months of labor into a streamlined cycle of rapid experimentation and data-driven refinement.

This move marks a distinct departure from Gaga’s earlier foray into the beauty industry with Haus Labs. While that brand focused on high-impact makeup, Outer Bio prioritizes the underlying science of skin health rather than direct-to-consumer sales. The couple’s collaboration reflects a broader creative partnership that has already influenced Gaga’s musical output and touring strategy. Despite the heavy reliance on automated screening, the singer has maintained that technological advancement does not replace the human element. Addressing the role of artificial intelligence in her recent creative work, she emphasized that human connection remains an irreplaceable component of artistic and scientific endeavors.